Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology (ASNC), explains two key advances in cardiac nuclear imaging.
 

The COVID lockdowns at the Shanghai plant began on March 31, and although the plant there has since resumed operations, they are not yet at 100% capacity.

All-cause mortality after one year was 4.6% for the TAVR group and 6.6% for the SAVR group

Terry Bowers, MD, director of vascular medicine at Beaumont Hospital and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the trend toward creating pulmonary embolism (PE) response teams that include cardiology. 

Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.

The first image of the black hole at the heart of our Milky Way galaxy amazed the scientific community, but left cardiologists with questions about the true cardiac health of the galaxy.

American College of Cardiology President Edward T. A. Fry, MD, discusses his general takeaways on technology advances seen during ACC.22.